These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3556347)

  • 1. VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
    Colwell JA; Bingham SF
    Haemostasis; 1986; 16(6):433-8. PubMed ID: 3556347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates.
    Colwell JA; Bingham SF; Abraira C; Anderson JW; Comstock JP; Kwaan HC; Nuttall F
    Diabetes Care; 1986; 9(2):140-8. PubMed ID: 3516608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V.A. Cooperative Study of antiplatelet agents in diabetic patients after amputation for gangrene: unobserved, sudden, and unexpected deaths.
    Colwell JA; Bingham SF; Abraira C; Anderson JW; Comstock JP; Kwaan HC; Nuttall F
    J Diabet Complications; 1989; 3(4):191-7. PubMed ID: 2533210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
    Colwell JA; Bingham SF; Abraira C; Anderson JW; Kwaan HC
    Horm Metab Res Suppl; 1985; 15():69-73. PubMed ID: 3908283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: I. Design, methods, and baseline characteristics.
    Colwell JA; Bingham SF; Abraira C; Anderson JW; Kwaan HC
    Control Clin Trials; 1984 Jun; 5(2):165-83. PubMed ID: 6378522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents: a review.
    Gantmacher ML
    J R Soc Med; 1979 Jul; 72(7):513-9. PubMed ID: 399644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gangrene of the toes and foot in persons suffering from diabetes mellitus].
    Sokolovskiĭ VD
    Khirurgiia (Mosk); 1966 Oct; 42(10):55-9. PubMed ID: 5999322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amputation in diabetic gangrene].
    Nowak W
    Dtsch Gesundheitsw; 1971 Sep; 26(38):1781-5. PubMed ID: 5142345
    [No Abstract]   [Full Text] [Related]  

  • 10. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiplatelet therapy and cerebrovascular diseases.
    Meloche JP
    Adv Otorhinolaryngol; 1982; 28():100-3. PubMed ID: 7051785
    [No Abstract]   [Full Text] [Related]  

  • 12. Gangrene of the upper extremity in diabetic patients.
    Lagaard SW; McElfresh EC; Premer RF
    J Bone Joint Surg Am; 1989 Feb; 71(2):257-64. PubMed ID: 2918010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipyridamole: a critical evaluation.
    Rivey MP; Alexander MR; Taylor JW
    Drug Intell Clin Pharm; 1984 Nov; 18(11):869-80. PubMed ID: 6389068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 16. The current status of platelet suppressive drugs in the treatment of thrombosis.
    Hirsh J; Gent M; Genton E
    Thromb Diath Haemorrh; 1975 Jun; 33(3):406-16. PubMed ID: 1098213
    [No Abstract]   [Full Text] [Related]  

  • 17. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T; Samama M
    Agents Actions Suppl; 1986; 20():203-14. PubMed ID: 3544741
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypercoagulation and thrombotic state in the pre-and postoperative period in diabetic gangrene of the lower extremities].
    Kuleshov EV; Kuleshova Iiu
    Sov Med; 1970; 33(5):80-5. PubMed ID: 5432975
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of common antiplatelet drugs for vascular diseases.
    Pagano T; Nair CK; Sketch MH
    Geriatrics; 1983 Nov; 38(11):75-95. PubMed ID: 6605278
    [No Abstract]   [Full Text] [Related]  

  • 20. Gangrene in the diabetic foot: its implications and consequences.
    Franke DR; Lenet M; Sherman M
    J Foot Surg; 1978; 17(3):112-7. PubMed ID: 753867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.